Bullous Pemphigoid Established by Direct Immunofluorescence: Case Report

Vidyani Adiningtyas, Hasnikmah Mappamasing, Septiana Widyantari, Trisiswati Indranarum, Sawitri, Evy Ervianti, Sunarko Martodiharjo, Dwi Murtiastutik

2018

Abstract

Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. It is characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous membranes. Collagen XVII and dystonin-e have been identified as target antigens. BP is usually a chronic disease, with spontaneous exacerbations and remissions. The diagnosis of BP relies on immunopathologic findings, especially based on both direct and indirect immunofluorescence microscopy observations, as well as on anti-BP180/BP230 enzyme-linked immunosorbent assays (ELISAs). The primary objectives are therefore to control both the skin eruption and itch, as well as to minimize any serious side-effects of the treatment.

Paper Citation

in Harvard Style

Adiningtyas V., Mappamasing H., Widyantari S., Indranarum T., Sawitri., Ervianti E., Martodiharjo S. and Murtiastutik D. (2018). Bullous Pemphigoid Established by Direct Immunofluorescence: Case Report.In Proceedings of the 23rd Regional Conference of Dermatology - Volume 1: RCD, ISBN 978-989-758-494-7, pages 347-350. DOI: 10.5220/0008157103470350

in Bibtex Style

@conference{rcd18,
author={Vidyani Adiningtyas and Hasnikmah Mappamasing and Septiana Widyantari and Trisiswati Indranarum and Sawitri and Evy Ervianti and Sunarko Martodiharjo and Dwi Murtiastutik},
title={Bullous Pemphigoid Established by Direct Immunofluorescence: Case Report},
booktitle={Proceedings of the 23rd Regional Conference of Dermatology - Volume 1: RCD,},
year={2018},
pages={347-350},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0008157103470350},
isbn={978-989-758-494-7},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 23rd Regional Conference of Dermatology - Volume 1: RCD,
TI - Bullous Pemphigoid Established by Direct Immunofluorescence: Case Report
SN - 978-989-758-494-7
AU - Adiningtyas V.
AU - Mappamasing H.
AU - Widyantari S.
AU - Indranarum T.
AU - Sawitri.
AU - Ervianti E.
AU - Martodiharjo S.
AU - Murtiastutik D.
PY - 2018
SP - 347
EP - 350
DO - 10.5220/0008157103470350